CF PHARMTECH Facility Passes Key International Pharmaceutical Inspection

Stock News06-04

CF PHARMTECH (02652) has announced that its inhalation drug production facility located in Suzhou, China, has successfully passed an on-site Good Manufacturing Practice (GMP) compliance inspection conducted by a regulatory authority from a member state of the Pharmaceutical Inspection Co-operation Scheme (PIC/S).

The inspection covered the site's production management and quality control systems, premises, facilities, equipment, data integrity, and computerized systems.

Passing this inspection confirms that the facility's quality management system and production capabilities meet PIC/S GMP standards, opening a significant market access pathway for the company's inhalation products.

The targeted markets have populations in the hundreds of millions and bear a heavy burden of chronic respiratory diseases, including asthma and chronic obstructive pulmonary disease (COPD), yet the accessibility of inhalation therapies in these regions remains below the international average.

The group had previously obtained China GMP certification and passed an audit by a European Union Qualified Person (QP).

This latest successful inspection by a PIC/S member state marks another milestone in the company's global expansion and supports its strategy of supplying high-quality, cost-effective inhalation products and respiratory disease solutions to overseas markets.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1153622309?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-04 21:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1153622309","market":"sh","top_or_hot":-1,"title":"CF PHARMTECH Facility Passes Key International Pharmaceutical Inspection","media":"Stock News","content":"<p><b>CF PHARMTECH</b> (<b>02652</b>) has announced that its inhalation drug production facility located in Suzhou, China, has successfully passed an on-site Good Manufacturing Practice (GMP) compliance inspection conducted by a regulatory authority from a member state of the Pharmaceutical Inspection Co-operation Scheme (PIC/S).<br><br>The inspection covered the site's production management and quality control systems, premises, facilities, equipment, data integrity, and computerized systems.<br><br>Passing this inspection confirms that the facility's quality management system and production capabilities meet PIC/S GMP standards, opening a significant market access pathway for the company's inhalation products.<br><br>The targeted markets have populations in the hundreds of millions and bear a heavy burden of chronic respiratory diseases, including asthma and chronic obstructive pulmonary disease (COPD), yet the accessibility of inhalation therapies in these regions remains below the international average.<br><br>The group had previously obtained China GMP certification and passed an audit by a European Union Qualified Person (QP).<br><br>This latest successful inspection by a PIC/S member state marks another milestone in the company's global expansion and supports its strategy of supplying high-quality, cost-effective inhalation products and respiratory disease solutions to overseas markets.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CF PHARMTECH Facility Passes Key International Pharmaceutical Inspection</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCF PHARMTECH Facility Passes Key International Pharmaceutical Inspection\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-06-04 21:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>CF PHARMTECH</b> (<b>02652</b>) has announced that its inhalation drug production facility located in Suzhou, China, has successfully passed an on-site Good Manufacturing Practice (GMP) compliance inspection conducted by a regulatory authority from a member state of the Pharmaceutical Inspection Co-operation Scheme (PIC/S).<br><br>The inspection covered the site's production management and quality control systems, premises, facilities, equipment, data integrity, and computerized systems.<br><br>Passing this inspection confirms that the facility's quality management system and production capabilities meet PIC/S GMP standards, opening a significant market access pathway for the company's inhalation products.<br><br>The targeted markets have populations in the hundreds of millions and bear a heavy burden of chronic respiratory diseases, including asthma and chronic obstructive pulmonary disease (COPD), yet the accessibility of inhalation therapies in these regions remains below the international average.<br><br>The group had previously obtained China GMP certification and passed an audit by a European Union Qualified Person (QP).<br><br>This latest successful inspection by a PIC/S member state marks another milestone in the company's global expansion and supports its strategy of supplying high-quality, cost-effective inhalation products and respiratory disease solutions to overseas markets.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1191","symbol_name":"制药","start_time":0,"source_url":"","article_id":"1153622309","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1153622309","pubTimestamp":1780579349,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"CF PHARMTECH (02652) has announced that its inhalation drug production facility located in Suzhou, China, has successfully passed an on-site Good Manufacturing Practice (GMP) compliance inspection...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1191":"制药","02652":"长风药业"},"translate_title":"CF PHARMTECH工厂通过关键国际制药检查","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02652":1},"content_text":"CF PHARMTECH (02652) has announced that its inhalation drug production facility located in Suzhou, China, has successfully passed an on-site Good Manufacturing Practice (GMP) compliance inspection conducted by a regulatory authority from a member state of the Pharmaceutical Inspection Co-operation Scheme (PIC/S).The inspection covered the site's production management and quality control systems, premises, facilities, equipment, data integrity, and computerized systems.Passing this inspection confirms that the facility's quality management system and production capabilities meet PIC/S GMP standards, opening a significant market access pathway for the company's inhalation products.The targeted markets have populations in the hundreds of millions and bear a heavy burden of chronic respiratory diseases, including asthma and chronic obstructive pulmonary disease (COPD), yet the accessibility of inhalation therapies in these regions remains below the international average.The group had previously obtained China GMP certification and passed an audit by a European Union Qualified Person (QP).This latest successful inspection by a PIC/S member state marks another milestone in the company's global expansion and supports its strategy of supplying high-quality, cost-effective inhalation products and respiratory disease solutions to overseas markets.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1153622309","isCrawlerRequest":true}